Pfizer's COVID pill Paxlovid gains full FDA approval
(VOVWORLD) - The US Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment, Paxlovid, clearing the way for the drugmaker to sell the drug at market rates once US government supplies dwindle.
 (Photo: Reuters) |
US officials have said they plan to work through much of the inventory of Paxlovid bought from Pfizer, which is available for free at pharmacies around the country, before moving to a normal commercial market for the drug.
Pfizer has sold the US government nearly 24 million courses of Paxlovid at around 530 USD a course. It is not clear yet what the commercial price will be for the drug.